Holen Sie sich die Stockscreener-App
39.56
3.02%
1.16
Handel nachbörslich:
37.27
-2.29
-5.79%
Schlusskurs vom Vortag:
$38.40
Offen:
$39.05
24-Stunden-Volumen:
71,476
Relative Volume:
0.86
Marktkapitalisierung:
$650.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.89%
1M Leistung:
+95.07%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$37.25
$39.95
1-Wochen-Bereich:
$36.12
$40.91
52-Wochen-Spanne:
$16.38
$40.91
Claritev Corp Stock (CTEV) Company Profile
Firmenname
Claritev Corp
Sektor
Branche
Telefon
212-780-2000
Adresse
7900 TYSONS ONE PLACE, MCLEAN
Vergleichen Sie CTEV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTEV
Claritev Corp
|
39.56 | 590.72M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
285.36 | 45.60B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
62.07 | 9.42B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
111.55 | 8.73B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
58.85 | 9.76B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
41.16 | 6.67B | 906.14M | -52.62M | 89.62M | -0.3621 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Neutral |
| 2022-12-13 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-07-12 | Eingeleitet | Goldman | Neutral |
| 2021-10-04 | Fortgesetzt | Citigroup | Buy |
| 2021-04-07 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-19 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Claritev Corp Aktie (CTEV) Neueste Nachrichten
Michael Jordan’s NASCAR Team Denied Charter Bid After Appeals Court Ruling - PYMNTS.com
Judge denies MultiPlan, payers' motions to toss price-fixing litigation - Fierce Healthcare
US judge rules health insurers, MultiPlan must face price-fixing lawsuits - Reuters
Judge rejects bid to dismiss MultiPlan antitrust complaints - Modern Healthcare
Claritev Upgraded to Overweight at Piper Sandler with a $44 Price Target - MSN
Piper Sandler Upgrades Claritev (CTEV) - Nasdaq
Piper Sandler lifts Claritev stock rating to Overweight, PT to $44 By Investing.com - Investing.com South Africa
Claritev Shares Rise After Upgrade From Piper Sandler - marketscreener.com
CTEV Stock Upgraded: Piper Sandler Raises Price Target Significa - GuruFocus
CTEV Stock Upgraded: Piper Sandler Raises Price Target Significantly | CTEV Stock News - GuruFocus
Claritev Corp (CTEV) Stock Price Up 28.09% on May 29 - GuruFocus
Claritev (CTEV) Surges Over 30% with Significant Price Increase | CTEV Stock News - GuruFocus
Piper Sandler Upgrades Claritev to Overweight From Neutral, Adjusts Price Target to $44 From $19 - marketscreener.com
Piper Sandler lifts Claritev stock rating to Overweight, PT to $44 - Investing.com Australia
Claritev (CTEV) Stock Upgraded by Piper Sandler with Increased Price Target | CTEV Stock News - GuruFocus
Claritev upgraded to Overweight from Neutral at Piper Sandler - TipRanks
Claritev (CTEV) Receives Upgrade to Overweight by Piper Sandler | CTEV Stock News - GuruFocus
Claritev Appoints Mohamed Ramzy as SVP and General Manager, International to Lead Geographic Expansion; Signs with Halian to Support Regional Operations - Business Wire
Claritev Corporation (CTEV) Stock Analysis: Navigating the Healthcare Data Landscape Amidst a Volatile Market - DirectorsTalk Interviews
Claritev and Burjeel Holdings Finalize Strategic Collaboration, Marks Claritev’s Expansion into the Middle East - 01net
Claritev Corporation and Claims Care Revenue Cycle Management Llc Finalize Strategic Collaboration, Marks Claritev's Expansion into the Middle East - marketscreener.com
Claritev and Burjeel Holdings partner on healthcare tech By Investing.com - Investing.com Nigeria
Claritev, Burjeel Holdings finalize strategic collaboration - TipRanks
Claritev and Burjeel Holdings Finalize Strategic Collaboration, - GuruFocus
CTEV Stock Trading Resumes: Key Insights and Developments | CTEV - GuruFocus
CTEV Stock Trading Resumes: Key Insights and Developments | CTEV Stock News - GuruFocus
Claritev (CTEV) and Claims Care Forge Strategic Partnership for MENA Region | CTEV Stock News - GuruFocus
Claritev and Burjeel Holdings Finalize Strategic Collaboration, Marks Claritev's Expansion into the Middle East | CTEV Stock News - GuruFocus
Claritev and Burjeel Holdings partner on healthcare tech - Investing.com
CTEV Trading Halted Pending News Announcement | CTEV Stock News - GuruFocus
Claritev Corp Executives Acquire Shares - TradingView
Claritev Corporation Braces for Impact: Navigating Potential U.S. Tax Law Changes - TipRanks
Insider Buying: Travis Dalton Acquires Additional Shares of Claritev Corp (CTEV) - GuruFocus
Executive VP & CFO of Claritev Picks Up 76% More Stock - Yahoo Finance
Hedge Fund and Insider Trading News: Ray Dalio, David Einhorn, Rob Citrone, Jim Chanos, Jeffrey Talpins, Bill Ackman, Warren Buffett, Whitney Tilson, Elliott Management, Claritev Corp (CTEV), Yum! Brands Inc (YUM), and More - Insider Monkey
Claritev Corporation (NYSE:CTEV) Shares Fly 30% But Investors Aren't Buying For Growth - simplywall.st
Claritev’s CFO Makes a Bold Move with Major Stock Purchase! - TipRanks
Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue Estimates - MSN
Claritev Corp (CTEV) Q1 2025 Earnings Call Highlights: Strategic Wins Amid Revenue Challenges - Yahoo Finance
Earnings call transcript: Claritev Corp Q1 2025 sees revenue dip, stock reacts negatively - Investing.com
Claritev Corporation Reports Q1 2025 Financial Results - TipRanks
Transcript : Claritev Corporation, Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com
Claritev Q1 2025 slides: Revenue dips 1.4%, Payment Integrity segment shines - Investing.com
Claritev Corp Reports Q1 2025 Revenue of $231.3M, Surpassing Est - GuruFocus
Claritev Corp Reports Q1 2025 Revenue of $231.3M, Surpassing Estimates; Faces Net Loss of $71.3M - GuruFocus
Claritev Corporation Reports First Quarter 2025 Results | CTEV S - GuruFocus
Claritev Corporation Reports First Quarter 2025 Results - TradingView
Claritev partners with Lantern to optimize healthcare costs By Investing.com - Investing.com South Africa
Claritev (CTEV) Partners with Lantern to Boost Surgical Cost Transparency | CTEV Stock News - GuruFocus
Claritev partners with Lantern to optimize healthcare costs - Investing.com
Finanzdaten der Claritev Corp-Aktie (CTEV)
Es liegen keine Finanzdaten für Claritev Corp (CTEV) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
4.00%
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):